279 related articles for article (PubMed ID: 21396918)
1. Distinct pharmacological properties of morphine metabolites at G(i)-protein and β-arrestin signaling pathways activated by the human μ-opioid receptor.
Frölich N; Dees C; Paetz C; Ren X; Lohse MJ; Nikolaev VO; Zenk MH
Biochem Pharmacol; 2011 May; 81(10):1248-54. PubMed ID: 21396918
[TBL] [Abstract][Full Text] [Related]
2. Enhanced morphine analgesia in mice lacking beta-arrestin 2.
Bohn LM; Lefkowitz RJ; Gainetdinov RR; Peppel K; Caron MG; Lin FT
Science; 1999 Dec; 286(5449):2495-8. PubMed ID: 10617462
[TBL] [Abstract][Full Text] [Related]
3. A G protein-biased ligand at the μ-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine.
DeWire SM; Yamashita DS; Rominger DH; Liu G; Cowan CL; Graczyk TM; Chen XT; Pitis PM; Gotchev D; Yuan C; Koblish M; Lark MW; Violin JD
J Pharmacol Exp Ther; 2013 Mar; 344(3):708-17. PubMed ID: 23300227
[TBL] [Abstract][Full Text] [Related]
4. Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence.
Bohn LM; Gainetdinov RR; Lin FT; Lefkowitz RJ; Caron MG
Nature; 2000 Dec; 408(6813):720-3. PubMed ID: 11130073
[TBL] [Abstract][Full Text] [Related]
5. β-Arrestin 2 and ERK1/2 Are Important Mediators Engaged in Close Cooperation between TRPV1 and µ-Opioid Receptors in the Plasma Membrane.
Melkes B; Markova V; Hejnova L; Novotny J
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32610605
[TBL] [Abstract][Full Text] [Related]
6. β-Arrestin-2 knockout prevents development of cellular μ-opioid receptor tolerance but does not affect opioid-withdrawal-related adaptations in single PAG neurons.
Connor M; Bagley EE; Chieng BC; Christie MJ
Br J Pharmacol; 2015 Jan; 172(2):492-500. PubMed ID: 24597632
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of EGF-induced ERK/MAP kinase-mediated astrocyte proliferation by mu opioids: integration of G protein and beta-arrestin 2-dependent pathways.
Miyatake M; Rubinstein TJ; McLennan GP; Belcheva MM; Coscia CJ
J Neurochem; 2009 Jul; 110(2):662-74. PubMed ID: 19457093
[TBL] [Abstract][Full Text] [Related]
8. Assessment of structure-activity relationships and biased agonism at the Mu opioid receptor of novel synthetic opioids using a novel, stable bio-assay platform.
Vasudevan L; Vandeputte M; Deventer M; Wouters E; Cannaert A; Stove CP
Biochem Pharmacol; 2020 Jul; 177():113910. PubMed ID: 32179045
[TBL] [Abstract][Full Text] [Related]
9. Noribogaine is a G-protein biased κ-opioid receptor agonist.
Maillet EL; Milon N; Heghinian MD; Fishback J; Schürer SC; Garamszegi N; Mash DC
Neuropharmacology; 2015 Dec; 99():675-88. PubMed ID: 26302653
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo activity of cyclopeptide Dmt-c[d-Lys-Phe-Asp]NH
Gach-Janczak K; Piekielna-Ciesielska J; Adamska-Bartłomiejczyk A; Wtorek K; Ferrari F; Calo' G; Szymaszkiewicz A; Piasecka-Zelga J; Janecka A
Peptides; 2018 Jul; 105():51-57. PubMed ID: 29684591
[TBL] [Abstract][Full Text] [Related]
11. Live cell monitoring of mu-opioid receptor-mediated G-protein activation reveals strong biological activity of close morphine biosynthetic precursors.
Nikolaev VO; Boettcher C; Dees C; Bünemann M; Lohse MJ; Zenk MH
J Biol Chem; 2007 Sep; 282(37):27126-27132. PubMed ID: 17616524
[TBL] [Abstract][Full Text] [Related]
12. Usefulness for the combination of G-protein- and β-arrestin-biased ligands of μ-opioid receptors: Prevention of antinociceptive tolerance.
Mori T; Kuzumaki N; Arima T; Narita M; Tateishi R; Kondo T; Hamada Y; Kuwata H; Kawata M; Yamazaki M; Sugita K; Matsuzawa A; Baba K; Yamauchi T; Higashiyama K; Nonaka M; Miyano K; Uezono Y; Narita M
Mol Pain; 2017; 13():1744806917740030. PubMed ID: 29056067
[TBL] [Abstract][Full Text] [Related]
13. Possible biased analgesic of hydromorphone through the G protein-over β-arrestin-mediated pathway: cAMP, CellKey™, and receptor internalization analyses.
Manabe S; Miyano K; Fujii Y; Ohshima K; Yoshida Y; Nonaka M; Uzu M; Matsuoka Y; Sato T; Uezono Y; Morimatsu H
J Pharmacol Sci; 2019 Jun; 140(2):171-177. PubMed ID: 31320243
[TBL] [Abstract][Full Text] [Related]
14. An opioid agonist that does not induce mu-opioid receptor--arrestin interactions or receptor internalization.
Groer CE; Tidgewell K; Moyer RA; Harding WW; Rothman RB; Prisinzano TE; Bohn LM
Mol Pharmacol; 2007 Feb; 71(2):549-57. PubMed ID: 17090705
[TBL] [Abstract][Full Text] [Related]
15. A unique role of RGS9-2 in the striatum as a positive or negative regulator of opiate analgesia.
Psifogeorgou K; Terzi D; Papachatzaki MM; Varidaki A; Ferguson D; Gold SJ; Zachariou V
J Neurosci; 2011 Apr; 31(15):5617-24. PubMed ID: 21490202
[TBL] [Abstract][Full Text] [Related]
16. RGS9-2 is a negative modulator of mu-opioid receptor function.
Psifogeorgou K; Papakosta P; Russo SJ; Neve RL; Kardassis D; Gold SJ; Zachariou V
J Neurochem; 2007 Oct; 103(2):617-25. PubMed ID: 17725581
[TBL] [Abstract][Full Text] [Related]
17. Agonist-directed interactions with specific beta-arrestins determine mu-opioid receptor trafficking, ubiquitination, and dephosphorylation.
Groer CE; Schmid CL; Jaeger AM; Bohn LM
J Biol Chem; 2011 Sep; 286(36):31731-41. PubMed ID: 21757712
[TBL] [Abstract][Full Text] [Related]
18. Activation of Mas oncogene-related gene (Mrg) C receptors enhances morphine-induced analgesia through modulation of coupling of μ-opioid receptor to Gi-protein in rat spinal dorsal horn.
Wang D; Chen T; Zhou X; Couture R; Hong Y
Neuroscience; 2013 Dec; 253():455-64. PubMed ID: 24042038
[TBL] [Abstract][Full Text] [Related]
19. Novel Opioid Analgesics for the Development of Transdermal Opioid Patches That Possess Morphine-Like Pharmacological Profiles Rather Than Fentanyl: Possible Opioid Switching Alternatives Among Patch Formula.
Komatsu A; Miyano K; Nakayama D; Mizobuchi Y; Uezono E; Ohshima K; Karasawa Y; Kuroda Y; Nonaka M; Yamaguchi K; Iseki M; Uezono Y; Hayashida M
Anesth Analg; 2022 May; 134(5):1082-1093. PubMed ID: 35427270
[TBL] [Abstract][Full Text] [Related]
20. Biased Opioid Ligands.
Faouzi A; Varga BR; Majumdar S
Molecules; 2020 Sep; 25(18):. PubMed ID: 32948048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
